Yup Channel5, Saudi Arabia/Bahrain was a trial run
Post# of 8540
(Total Views: 384)
Posted On: 07/20/2022 5:59:25 PM
Yup Channel5, Saudi Arabia/Bahrain was a trial run for STADA and they must have liked the results.
A Big Congrats to Erin Sanders for landing this major company!!
BIEL was not specific with the scope of the new STADA distribution deal, hopefully we get a PR soon with the details.
This is a distribution deal for BIEL's ActiPatch not an OEM contract so there should be more margin involved for BIEL.
This deal is a Big Deal as STADA is serious about Growth and Increasing Revenue.
* Servicing customers in 120 countries
* 2021 Revenue of $3.59 Billion
* 8% Revenue gain from 2020 to 2021
* 12,300 Employees
* STADA has been growing agressively for several years
* 1/2022 STADA expands production network with EUR50m project in Romania
* 6/2021 STADA further grows European Consumer Healthcare portfolio by acquiring 16 well-established brands from Sanofi
* 12/2020 STADA delivers double-digit growth in 2019 as it invests to lead Consumer Healthcare and Generics core segments
* 5/2020 STADA closes acquisition of Walmark, creating a winning portfolio for Central Europe
* 4/2020 STADA takes clear lead in Russian consumer healthcare sector $660 million transaction of a Russian brand portfolio from Takeda
* 2/2020 STADA becomes a major Consumer Healthcare player by acquiring 15 well-established GSK brands
* 22020 STADA to acquire established OTC and food supplement portfolio in the Philippines
A Big Congrats to Erin Sanders for landing this major company!!
BIEL was not specific with the scope of the new STADA distribution deal, hopefully we get a PR soon with the details.
This is a distribution deal for BIEL's ActiPatch not an OEM contract so there should be more margin involved for BIEL.
This deal is a Big Deal as STADA is serious about Growth and Increasing Revenue.
* Servicing customers in 120 countries
* 2021 Revenue of $3.59 Billion
* 8% Revenue gain from 2020 to 2021
* 12,300 Employees
* STADA has been growing agressively for several years
* 1/2022 STADA expands production network with EUR50m project in Romania
* 6/2021 STADA further grows European Consumer Healthcare portfolio by acquiring 16 well-established brands from Sanofi
* 12/2020 STADA delivers double-digit growth in 2019 as it invests to lead Consumer Healthcare and Generics core segments
* 5/2020 STADA closes acquisition of Walmark, creating a winning portfolio for Central Europe
* 4/2020 STADA takes clear lead in Russian consumer healthcare sector $660 million transaction of a Russian brand portfolio from Takeda
* 2/2020 STADA becomes a major Consumer Healthcare player by acquiring 15 well-established GSK brands
* 22020 STADA to acquire established OTC and food supplement portfolio in the Philippines
(5)
(0)